MULT news

Franklin Multisector Income · Biotechnology · United States

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Seeking Alpha · 28 Oct 2026, 17:33 UTC
Ligand Pharmaceuticals Q3 2026 Earnings Preview | Seeking Alpha
4.6% of MULT
24/7 Wall St. · 28 Oct 2026, 19:24 UTC
16% of Employers Are Thinking About Cutting Weight-Loss Drug Coverage
3.0% of MULT
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
3.2% of MULT
Market Screener · 28 Oct 2026, 12:21 UTC
United Therapeutics Corporation Receives FDA Clearance To Proceed With Clinical Trial For Treprostinil-Iloprost SMI In Pulmonary Arterial Hypertension
3.5% of MULT
Where to buy MULT
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
RTTNews · 28 Oct 2026, 11:38 UTC
United Therapeutics Gets FDA Clearance To Begin Trial Of Inhaled PAH Therapy
3.5% of MULT
Investing.com · 28 Oct 2026, 11:12 UTC
United Therapeutics gets FDA nod for PAH combination therapy trial By Investing.com
3.5% of MULT
Where to buy MULT
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
wallstreet:online · 28 Oct 2026, 11:05 UTC
United Therapeutics Announces FDA Clearance to Proceed with Clinical Trial for Treprostinil-Iloprost SMI in Pulmonary Arterial Hypertension
3.5% of MULT
Seeking Alpha · 28 Oct 2026, 15:55 UTC
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE) | Seeking Alpha
3.0% of MULT
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
3.0% of MULT
Benzinga · 28 Oct 2026, 13:25 UTC
Eli Lilly Says Retatrutide Delivers More Than Double Ozempic's Weight Loss in Late-Stage Diabetes Trial -
3.0% of MULT
Investing.com · 28 Oct 2026, 14:08 UTC
Why is Twist Bioscience stock surging today? By Investing.com
2.8% of MULT
24/7 Wall St. · 28 Oct 2026, 12:14 UTC
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
3.0% of MULT
Market Screener · 28 Oct 2026, 12:07 UTC
Eli Lilly And Company Announces Positive Topline Results From TRANSCEND-T2D-2 Phase 3 Trial Of Retatrutide In Adults With Type 2 Diabetes
3.0% of MULT
wallstreet:online · 28 Oct 2026, 12:05 UTC
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
2.8% of MULT
Benzinga · 28 Oct 2026, 10:04 UTC
Top Wall Street Forecasters Revamp Eli Lilly Expectations Ahead Of Q3 Earnings - Eli Lilly (NYSE:LLY)
3.0% of MULT
wallstreet:online · 28 Oct 2026, 12:05 UTC
AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing
2.7% of MULT
The Manila times · 28 Oct 2026, 11:31 UTC
Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization
2.7% of MULT
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
3.0% of MULT
Seeking Alpha · 27 Oct 2026, 14:16 UTC
Adaptive Biotechnologies: Getting Paid Every Step Of The Way To A Myeloma Cure (ADPT) | Seeking Alpha
4.0% of MULT
www.theepochtimes.com · 28 Oct 2026, 00:00 UTC
Judge Declines to Block Eli Lilly Weight-Loss Drug Ads in Dispute With Novo Nordisk
3.0% of MULT

MULT news

Where to buy MULT

Where to buy MULT